Glutamine homeostasis regulates PD-L1 level through STAT3 in pancreatic cancer

Read full text
Authors: Zeyu Li, Wuxiyar Otkur, Huan Qi, Jinghan Li, Siyi Li, Ting Ling, Huaitao Wang, Rui Li, Qi Zhang, Yaguang Sun, Wei Pan, Hai-long Piao
+2 more Tian Xia, Xiaodong Tan
Cited by: 1
References: 62

Abstract

Glutamine is one of the most important metabolites and energy sources for cancer cell proliferation. However, the function of glutamine homeostasis to modulate immunotherapy by regulating immune checkpoint protein expression remains elusive. Here, we report that glutamine abundance increases the expression of the immune checkpoint protein PD-L1 through STAT3 signaling in pancreatic cancer cells. Mechanistically, STAT3 directly interacts with PD-L1 under glutamine stimulation and stabilizes PD-L1 protein by preventing it from ubiquitination and degradation. Additionally, our study suggests that PD-L1 may respond to cellular glutamine levels to regulate mTOR activation and pancreatic cancer cell proliferation. Overall, our study unveils a novel mechanism by which glutamine up-regulates PD-L1 expression to activate mTOR and promote cell proliferation, highlighting a crucial role of PD-L1 in regulating the metabolism of glutamine in pancreatic cancer.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Cancer Hypoxia and Metabolism Immune cells in cancer

Publication details

Journal / source
Genes & Diseases
Publisher
Elsevier BV
Pages
102092–102092
Publication date
1 February 2026
Language
EN